Public Health Agency of Canada

On December 6, 2023, the Minister of Health was invited to appear before the Standing Committee on Health (HESA) as part of their study of the Government's Advanced Purchase Agreement for vaccines with Medicago. The attached briefing materials were prepared for this appearance.

This funding is designed to protect Canadians from vaccine preventable disease by supporting our health partners in three priority areas: Build capacity of Health Care Providers as vaccinators and vaccination promoters; Support Community-based COVID-19 Education, Promotion and Outreach; and Build...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

The COVID-19 Vaccination Coverage Survey (CVCS) targets all Canadian adults living in the 10 provinces and the capital cities of the 3 territories, except those who live: in institutions or collective dwellings; on-reserve. The purpose of the survey is to measure COVID-19 vaccination coverage in...

"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice (the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada. The journal publishes articles on disease...

This document also discusses an approach to managing COVID-19 vaccines that are administered in a manner that differs from the recommendations of the manufacturer as authorized by Health Canada and/or the recommendations for use by National Advisory Committee on Immunization (NACI). These are...

This page is a summary of National Advisory Committee on Immunization (NACI) statement: Recommendations on the use of COVID-19 vaccines.

This evergreen document will be updated as COVID-19 vaccines are authorized and become available for use in Canada, and as evidence on these vaccines and COVID-19 evolves. This table summarizes the latest changes to this current version. Please refer to the Table of updates for a full list of...

As businesses safely reopen and vaccination rates increase, continuing to test and screen for COVID-19 can help prevent outbreaks, maintain safe workplaces and keep the economy running.

Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed in this document.

Pregnancy increases the risk of severe illness from COVID-19. The National Advisory Committee on Immunization (NACI) recommends you get a complete series with an mRNA COVID-19 vaccine if you're pregnant or breastfeeding. Getting the COVID-19 vaccine can prevent serious illness, hospitalization...

The health and safety of Canadians is our priority. Along with measures reported in the Government of Canada's response to COVID-19, Health Canada introduced innovative and agile regulatory measures to make health products available to Canadians and health care workers. The COVID-19 pandemic...

The coronavirus disease (COVID-19) pandemic has had unprecedented consequences for Canada's aging population with the majority of COVID-19 deaths (approximately 80% during 2020) occurring among adults aged 65 years and older. Both advanced age and underlying chronic diseases and conditions...

Monthly recap of health product safety information. The following is a list of health product advisories, type I recalls and summaries of completed safety reviews published in September 2021 by Health Canada.

Before becoming pregnant, talk to your health care provider or local public health authority to make sure your vaccines are up to date. Some vaccines are generally not recommended during pregnancy. Live vaccines such as MMR (mumps, measles and rubella) and chicken pox (varicella) should be given...

This report presents evidence-informed recommendations for testing a vaccinated population and vaccinated individuals.

Drugs included on this list are called "designated drugs" and are eligible for the exceptional importation and sale provisions provided for in Interim Order No. 2. Health Canada maintains and updates the list as required. It’s the same list that was incorporated by reference in the previous IO...

The Pfizer-BioNTech and Moderna COVID-19 vaccines are mRNA vaccines that were initially authorized by Health Canada for use in individuals 16 and 18 years of age and older, respectively, in December 2020. On May 5, 2021, Health Canada expanded the Interim Order authorization for the...

When people still show symptoms of COVID-19 for weeks or months after their initial recovery, it’s called post COVID-19 condition. It’s also known as long COVID. Post COVID-19 condition may occur in some people after infection.